Display options
Cite
Feld JJ, Foster GR. Corrigendum to "Second generation direct-acting antivirals - do we expect major improvements?". J Hepatol. 2017;66(5):1105doi: 10.1016/j.jhep.2017.02.015.
Feld, J. J., & Foster, G. R. (2017). Corrigendum to "Second generation direct-acting antivirals - do we expect major improvements?". Journal of hepatology, 66(5), 1105. https://doi.org/10.1016/j.jhep.2017.02.015
Feld, Jordan J, and Foster, Graham R. "Corrigendum to "Second generation direct-acting antivirals - do we expect major improvements?"." Journal of hepatology vol. 66,5 (2017): 1105. doi: https://doi.org/10.1016/j.jhep.2017.02.015
Feld JJ, Foster GR. Corrigendum to "Second generation direct-acting antivirals - do we expect major improvements?". J Hepatol. 2017 May;66(5):1105. doi: 10.1016/j.jhep.2017.02.015. Epub 2017 Mar 07. PMID: 28283248.
Copy Download .nbib Format: NLM
Share it on

J Hepatol. 2017 May;66(5):1105. doi: 10.1016/j.jhep.2017.02.015. Epub 2017 Mar 07.

Corrigendum to "Second generation direct-acting antivirals - do we expect major improvements?".

Journal of hepatology

Jordan J Feld, Graham R Foster

Affiliations

  1. Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada. Electronic address: [email protected].
  2. Queen Mary University London, London, UK. Electronic address: [email protected].

PMID: 28283248 DOI: 10.1016/j.jhep.2017.02.015

[No abstract available.]

Publication Types